scholarly journals Discovery of New Antibacterial Accramycins from a Genetic Variant of the Soil Bacterium, Streptomyces sp. MA37

Biomolecules ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. 1464
Author(s):  
Fleurdeliz Maglangit ◽  
Yuting Zhang ◽  
Kwaku Kyeremeh ◽  
Hai Deng
Keyword(s):  
Wild Type Strain ◽  
Biosynthetic Gene Cluster ◽  
Multidrug Resistant ◽  
Regulatory Genes ◽  
Negative Regulator ◽  
Clinical Isolates ◽  
Streptomyces Sp ◽  
In The Wild ◽  
A Minor ◽  
New Metabolites

Continued mining of natural products from the strain Streptomyces sp. MA37 in our laboratory led to the discovery of a minor specialized metabolite (SM) called accramycin A. Owing to its low yield (0.2 mg/L) in the wild type strain, we investigated the roles of regulatory genes in the corresponding biosynthetic gene cluster (acc BGC) through gene inactivation with the aim of improving the titer of this compound. One of the resulting mutants (∆accJ) dramatically upregulated the production of accramycin A 1 by 330-fold (66 mg/L). Furthermore, ten new metabolites, accramycins B–K 2–11, were discovered, together with two known compounds, naphthacemycin B112 and fasamycin C 13 from the mutant extract. This suggested that accJ, annotated as multiple antibiotic resistance regulator (MarR), is a negative regulator gene in the accramycin biosynthesis. Compounds 1–13 inhibited the Gram-positive pathogens (Staphylococcus aureus, Enterococcus faecalis) and clinical isolates Enterococcus faecium (K59-68 and K60-39) and Staphylococcus haemolyticus with minimal inhibitory concentration (MIC) values in the range of 1.5–12.5 µg/mL. Remarkably, compounds 1–13 displayed superior activity against K60-39 (MIC = 3.1–6.3 µg/mL) compared to ampicillin (MIC = 25 µg/mL), and offered promising potential for the development of accramycin-based antibiotics that target multidrug-resistant Enterococcus clinical isolates. Our results highlight the importance of identifying the roles of regulatory genes in natural product discovery.

scholarly journals Discovery of new antibacterial accramycins from a genetic variant of the soil bacterium, Streptomyces sp. MA37

2020 ◽  
Author(s):  
Fleurdeliz Maglangit ◽  
Yuting Zhang ◽  
Kwaku Kyeremeh ◽  
Hai Deng
Keyword(s):  
Wild Type Strain ◽  
Biosynthetic Gene Cluster ◽  
Multidrug Resistant ◽  
Regulatory Genes ◽  
Negative Regulator ◽  
Clinical Isolates ◽  
Wild Type ◽  
In The Wild ◽  
A Minor ◽  
New Metabolites

AbstractContinued mining of natural products from the strain Streptomyces sp. MA37 in our laboratory led to the discovery of a minor specialised metabolite (SM) called accramycin A. Owing to its low yield (0.2mg/L) in the wild type strain, we investigated the roles of regulatory genes in the corresponding biosynthetic gene cluster (acc BGC) through gene inactivation with the aim of improving the titre of this compound. One of the resulting mutants (ΔaccJ) dramatically upregulated the production of accramycin A 1 by 330-fold (66mg/L). Furthermore, ten new metabolites, accramycins B-K 2-11, were discovered, together with two known compounds, naphthacemycin B112 and fasamycin C 13 from the mutant extract. This suggested that accJ, annotated as Multiple Antibiotic Resistance Regulator (MarR), is a negative regulator gene in the accramycin biosynthesis. Compounds 1-13 inhibited the Gram-positive pathogens (S. aureus, E. faecalis) and clinical isolates, E. faecium (K59-68 and K60-39), and S. haemolyticus with minimal inhibitory concentration (MIC) values in the range of 1.5-12.5µg/mL. Remarkably, compounds 1-13 displayed superior activity against K60-39 (MIC = 3.1-6.3µg/mL) than ampicillin (MIC = 25µg/mL), and offer promising potential for the development of accramycin-based antibiotics that target multidrug-resistant Enterococcus clinical isolates. Our results highlight the importance of identifying the roles of regulatory genes in natural product discovery.

Efflux pump gene expression study using RNA-seq in multidrug-resistant TB

2021 ◽  
Vol 25 (12) ◽  
pp. 974-981
Author(s):  
J. J. Lee ◽  
H. Y. Kang ◽  
W-I. Lee ◽  
S. Y. Cho ◽  
Y. J. Kim ◽  
...  
Keyword(s):  
Wild Type Strain ◽  
Efflux Pump ◽  
Expression Patterns ◽  
Resistance Mechanism ◽  
Multidrug Resistant ◽  
Regulatory Genes ◽  
Control Group ◽  
Rna Expression ◽  
Rna Seq ◽  
Expression Study

BACKGROUND: The mechanism underlying kanamycin (KM) resistance in Mycobacterium tuberculosis is not well understood, although efflux pump proteins are thought to play a role. This study used RNA-seq data to investigate changes in the expression levels of efflux pump genes following exposure to KM.METHODS: RNA expression of efflux pump and regulatory genes following exposure to different concentrations of KM (minimum inhibitory concentration MIC 25 and MIC50) in rrs wild-type strain and rrs A1401G mutated strain were compared with the control group.RESULTS: The selected strains had differential RNA expression patterns. Among the 71 putative efflux pump and regulatory genes, 46 had significant fold changes, and 12 genes (Rv0842, Rv1146, Rv1258c, Rv1473, Rv1686c, Rv1687c, Rv1877, Rv2038c, Rv3065, Rv3197a, Rv3728 and Rv3789) that were overexpressed following exposure to KM were thought to contribute to drug resistance. Rv3197A (whiB7) showed a distinct fold change based on the concentration of KM.CONCLUSION: The significant changes in the expression of the efflux pump and regulatory genes following exposure to KM may provide insights into the identification of a new resistance mechanism.

scholarly journals Mutations in Four Regulatory Genes Have Interrelated Effects on Heterocyst Maturation in Anabaena sp. Strain PCC 7120

2006 ◽  
Vol 188 (21) ◽  
pp. 7387-7395 ◽  
Author(s):  
Sigal Lechno-Yossef ◽  
Qing Fan ◽  
Shigeki Ehira ◽  
Naoki Sato ◽  
C. Peter Wolk
Keyword(s):  
Type Strain ◽  
Wild Type Strain ◽  
Response Regulator ◽  
Regulatory System ◽  
Transcript Abundance ◽  
Regulatory Genes ◽  
Wild Type ◽  
Serine Threonine Kinase ◽  
In The Wild ◽  
Pcc 7120

ABSTRACT Regulatory genes hepK, hepN, henR, and hepS are required for heterocyst maturation in Anabaena sp. strain PCC 7120. They presumptively encode two histidine kinases, a response regulator, and a serine/threonine kinase, respectively. To identify relationships between those genes, we compared global patterns of gene expression, at 14 h after nitrogen step-down, in corresponding mutants and in the wild-type strain. Heterocyst envelopes of mutants affected in any of those genes lack a homogeneous, polysaccharide layer. Those of a henR mutant also lack a glycolipid layer. patA, which encodes a positive effector of heterocyst differentiation, was up-regulated in all mutants except the hepK mutant, suggesting that patA expression may be inhibited by products related to heterocyst development. hepS and hepK were up-regulated if mutated and so appear to be negatively autoregulated. HepS and HenR regulated a common set of genes and so appear to belong to one regulatory system. Some nontranscriptional mechanism may account for the observation that henR mutants lack, and hepS mutants possess, a glycolipid layer, even though both mutations down-regulated genes involved in formation of the glycolipid layer. HepK and HepN also affected transcription of a common set of genes and therefore appear to share a regulatory pathway. However, the transcript abundance of other genes differed very significantly from expression in the wild-type strain in either the hepK or hepN mutant while differing very little from wild-type expression in the other of those two mutants. Therefore, hepK and hepN appear to participate also in separate pathways.

scholarly journals Improvement of Nemadectin Production by Overexpressing the Regulatory Gene nemR and Nemadectin Biosynthetic Gene Cluster in Streptomyces Cyaneogriseus

2021 ◽  
Author(s):  
Yuan-Jie Wu ◽  
Song-Bai Yang ◽  
Zheng-Yu Zhang ◽  
Shao-Xin Chen
Keyword(s):  
Gene Cluster ◽  
Wild Type Strain ◽  
Regulatory Gene ◽  
Anthelmintic Activity ◽  
Biosynthetic Gene Cluster ◽  
Wild Type ◽  
Transcription Level ◽  
Positive Role ◽  
C 23 ◽  
In The Wild

AbstractNemadectin, a 16-member macrocyclic lactone antiparasitic antibiotic, is produced by Streptomyces cyaneogriseus subspecies noncyanogenus. Moxidectin, a C-23 oximate derivative of nemadectin, is widely used as a pesticide due to its broad-spectrum, highly efficient, and safe anthelmintic activity. NemR, a LAL family regulator, is encoded by nemR and is involved in nemadectin biosynthesis in S. cyaneogriseus. In this report, gene disruption and complementation experiments showed that nemR plays a positive role in the biosynthesis of nemadectin. The transcription level of nemadectin biosynthetic genes in the nemR knockout strain was significantly decreased compared with those in the wild-type strain MOX-101. However, overexpression of nemR under the control of native or strong constitutive promoters resulted in the opposite, increasing the production of nemadectin by 56.5 or 73.5%, respectively, when compared with MOX-101. In addition, the gene cluster of nemadectin biosynthesis was further cloned and overexpressed using a CRISPR method, which significantly increase nemadectin yield by 108.6% (509 mg/L) when compared with MOX-101.

scholarly journals Roles offkbNin Positive Regulation andtcs7in Negative Regulation of FK506 Biosynthesis in Streptomyces sp. Strain KCTC 11604BP

2012 ◽  
Vol 78 (7) ◽  
pp. 2249-2255 ◽  
Author(s):  
SangJoon Mo ◽  
Young Ji Yoo ◽  
Yeon Hee Ban ◽  
Sung-Kwon Lee ◽  
Eunji Kim ◽  
...  
Keyword(s):  
Type Strain ◽  
Wild Type Strain ◽  
Regulatory Protein ◽  
Strain Improvement ◽  
Transcriptional Regulators ◽  
Biosynthetic Gene Cluster ◽  
Wild Type ◽  
Biosynthetic Genes ◽  
Content Type ◽  
In The Wild

ABSTRACTFK506 is an important 23-member polyketide macrolide with immunosuppressant activity. Its entire biosynthetic gene cluster was previously cloned fromStreptomycessp. strain KCTC 11604BP, and sequence analysis identified three putative regulatory genes,tcs2,tcs7, andfkbN, which encode proteins with high similarity to the AsnC family transcriptional regulators, LysR-type transcriptional regulators, and LAL family transcriptional regulators, respectively. Overexpression and in-frame deletion oftcs2did not affect the production of FK506 or co-occurring FK520 compared to results for the wild-type strain, suggesting thattcs2is not involved in their biosynthesis.fkbNoverexpression improved the levels of FK506 and FK520 production by approximately 2.0-fold, and a deletion offkbNcaused the complete loss of FK506 and FK520 production. Although the overexpression oftcs7decreased the levels of FK506 and FK520 production slightly, a deletion oftcs7caused 1.9-fold and 1.5-fold increases in FK506 and FK520 production, respectively. Finally,fkbNoverexpression in thetcs7deletion strain resulted in a 4.0-fold (21 mg liter−1) increase in FK506 production compared to that by the wild-type strain. This suggests thatfkbNencodes a positive regulatory protein essential for FK506/FK520 biosynthesis and that the gene product oftcs7negatively regulates their biosynthesis, demonstrating the potential of exploiting this information for strain improvement. Semiquantitative reverse transcription-PCR (RT-PCR) analyses of the transcription levels of the FK506 biosynthetic genes in the wild-type and mutant strains proved that most of the FK506 biosynthetic genes are regulated byfkbNin a positive manner and negatively bytcs7.

scholarly journals Nystatin Biosynthesis and Transport: nysH and nysG Genes Encoding a Putative ABC Transporter System in Streptomyces noursei ATCC 11455 Are Required for Efficient Conversion of 10-Deoxynystatin to Nystatin

2005 ◽  
Vol 49 (11) ◽  
pp. 4576-4583 ◽  
Author(s):  
Håvard Sletta ◽  
Sven E. F. Borgos ◽  
Per Bruheim ◽  
Olga N. Sekurova ◽  
Hans Grasdalen ◽  
...  
Keyword(s):  
Wild Type Strain ◽  
Profile Analysis ◽  
Metabolite Profile ◽  
Biosynthetic Gene Cluster ◽  
Hydroxyl Group ◽  
Efflux System ◽  
Atpase Inhibitor ◽  
Streptomyces Noursei ◽  
Genes Encoding ◽  
In The Wild

ABSTRACT The genes nysH and nysG, encoding putative ABC-type transporter proteins, are located at the flank of the nystatin biosynthetic gene cluster in Streptomyces noursei ATCC 11455. To assess the possible roles of these genes in nystatin biosynthesis, they were inactivated by gene replacements leading to in-frame deletions. Metabolite profile analysis of the nysH and nysG deletion mutants revealed that both of them synthesized nystatin at a reduced level and produced considerable amounts of a putative nystatin analogue. Liquid chromatography-mass spectrometry and nuclear magnetic resonance structural analyses of the latter metabolite confirmed its identity as 10-deoxynystatin, a nystatin precursor lacking a hydroxyl group at C-10. Washing experiments demonstrated that both nystatin and 10-deoxynystatin are transported out of cells, suggesting the existence of an alternative efflux system(s) for the transport of nystatin-related metabolites. This notion was further corroborated in experiments with the ATPase inhibitor sodium o-vanadate, which affected the production of nystatin and 10-deoxynystatin in the wild-type strain and transporter mutants in a different manner. The data obtained in this study suggest that the efflux of nystatin-related polyene macrolides occurs through several transporters and that the NysH-NysG efflux system provides conditions favorable for C-10 hydroxylation.

scholarly journals Regulation of the Biosynthesis of the Macrolide Antibiotic Spiramycin in Streptomyces ambofaciens

2010 ◽  
Vol 192 (21) ◽  
pp. 5813-5821 ◽  
Author(s):  
Fatma Karray ◽  
Emmanuelle Darbon ◽  
Hoang Chuong Nguyen ◽  
Josette Gagnat ◽  
Jean-Luc Pernodet
Keyword(s):  
Expression Analysis ◽  
Wild Type Strain ◽  
Macrolide Antibiotic ◽  
Regulatory Gene ◽  
Biosynthetic Gene Cluster ◽  
Wild Type ◽  
Rt Pcr ◽  
Reverse Transcription Pcr ◽  
Streptomyces Ambofaciens ◽  
In The Wild

ABSTRACT Streptomyces ambofaciens synthesizes the macrolide antibiotic spiramycin. The biosynthetic gene cluster for spiramycin has been characterized for S. ambofaciens. In addition to the regulatory gene srmR (srm22), previously identified (M. Geistlich et al., Mol. Microbiol. 6:2019-2029, 1992), three putative regulatory genes had been identified by sequence analysis. Gene expression analysis and gene inactivation experiments showed that only one of these three genes, srm40, plays a major role in the regulation of spiramycin biosynthesis. The disruption of srm22 or srm40 eliminated spiramycin production while their overexpression increased spiramycin production. Expression analysis was performed by reverse transcription-PCR (RT-PCR) for all the genes of the cluster in the wild-type strain and in the srm22 (srmR) and srm40 deletion mutants. The results from the expression analysis, together with the ones from the complementation experiments, indicated that Srm22 is required for srm40 expression, Srm40 being a pathway-specific activator that controls most, if not all, of the spiramycin biosynthetic genes.

Sign in / Sign up

Export Citation Format

Share Document